HAVN LIFE SCIENCES (HAVLF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 18 34 sessions, December 26, 2024 to December 29, 2025
- Largest daily move
- +1800% close of November 14, 2025
- 1-year change
- -90% closing prices, December 26, 2024 to December 29, 2025
Company Description
HAVN LIFE SCIENCES (OTC: HAVLF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $326.4K.
HAVLF has declined 90.0% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for HAVLF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HAVN LIFE SCIENCES (HAVLF) closed at $0.0001 on December 29, 2025. Over the past 12 months, the price has lost 90.0%.
HAVLF Metrics & Rankings
Price returns through December 29, 2025. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
HAVN LIFE SCIENCES has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, clinical trial. View all HAVLF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
HAVLF Company Profile & Sector Positioning
HAVN LIFE SCIENCES (HAVLF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing HAVLF often look at related companies in the same sector, including AMARANTUS BIOSCIENCE HLDG (AMBS), WESANA HEALTH HLDGS INC (WSNAF), ALTAMIRA THERAPEUTICS LTD (CYTOF), BIOASIS TECHNOLOGIES INC (BIOAF), and RESPIRERX PHARMA INC (RSPI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate HAVLF's relative position within its industry.